Ionis Pharmaceuticals | IONS - Gewinn Vor Steuern

Aktienkurs
74.82
Täglich Wechseln
3.04 4.24%
Monatlich
3.17%
Jährlich
143.63%
Q2 Prognose
71.70




Gewinn Vor Steuern Veränderung Datum
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Astellas Pharma JPY 48.02B 85.93B 2026-03
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Exelixis USD 252.69M 275K 2025-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Ionis Pharmaceuticals USD -228M 99M 2025-12
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Moderna USD -187M 631M 2025-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Novartis USD 4.64B 445M 2025-12
Omeros USD -65.12M 21.27M 2024-06
OPKO Health USD -46.9M 88.33M 2025-12
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pfizer USD 3.33B 290M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Qiagen NV USD 109.17M 25.56M 2025-12
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Tilray USD -39.96M 39.19M 2025-09
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06